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Smokeless tobacco use has increased by 38.4% over the 
past decade, while other nicotine products have progressively 
decreased (U.S. Department of Agriculture [USDA], 1993). 
Among the estimated 10 million American smokeless users, over 
one third of them are below the age of 21 (Consensus Confer-
ence, 1986). Epidemiological studies have also shown a relation-
ship between smokeless use and oral cancers (Hoffmann, Adams, 
Lisk, Fisenne, & Brunnemann, 1987; Hoffmann et al., 1995). 
Smokeless tobacco use at younger ages and the health risks in-
volved with use necessitates more research examining smokeless 
tobacco effects (e.g., withdrawal). 
Tobacco-withdrawal research has primarily focused on de-
privation effects of smokers (Hughes & Hatsukami, 1986; 
Hughes, Higgins, & Hatsukami, 1990). Deprivation effects have 
been shown to begin within 24 hr and peak within 48 hr when 
compared to a baseline (prequit) period using self-report and 
physiological measurements (Hughes, Gust, Skoog, Keenan, & 
Fenwick, 1991; Hughes & Hatsukami, 1986). Smokeless tobacco 
studies have demonstrated comparable baseline cotinine levels 
(Gritz, Baer-Weiss, Benowitz, Van Vanakis, & Jarvik, 1981; Hat-
sukami, Gust, & Keenan, 1987) with subsequent deprivation pro-
ducing quantitatively less severe withdrawal (Hatsukami et al., 
1987). It was speculated that the differences in withdrawal sever-
ity may have been infl uenced by differential absorption rates, car-
bon monoxide effects, anticipatory effects, or all of these (Hatsu-
kami et al., 1987). 
Studies examining withdrawal patterns have consistently 
used 2 or 3 days of ad lib nicotine use before deprivation (Hat-
sukami et al., 1987; Hughes & Hatsukami, 1986; Hughes et al., 
1990). Although this research suggests the importance of stabi-
lizing nondeprivation responses before deprivation (Hatsukami et 
al., 1987), researchers have not clearly documented that multiple 
nondeprivation days effectively stabilize the response pattern and 
control for demand characteristics. It is still unclear whether other 
factors, such as novelty or anticipation, signifi cantly infl uence 
deprivation effects. For example, Hatsukami et al. speculated 
that the anticipation of prolonged abstinence may have contrib-
uted to cigarette smokers’ higher withdrawal severity compared 
to smokeless users. Hatsukami et al. used smokers who enrolled 
in a treatment program and who intended to abstain permanently 
from smoking, whereas smokeless users expected to abstain for 
only 48 hr. This motivational difference may have infl uenced the 
results. Future research should focus on controlling for these ef-
fects. It is suggested that by counterbalancing nondeprivation and 
deprivation days we may get a clearer understanding of the stabi-
lization process, help minimize novelty and anticipatory effects, 
and elicit a more accurate index of tobacco withdrawal. 
This study addressed differences between cigarette smok-
ers’ and smokeless users’ total withdrawal symptoms, withdrawal 
based on the American Psychiatric Association’s Diagnostic and 
Statistical Manual of Mental Disorders, 4th edition (DSM-IV; 
American Psychiatric Association, 1994) criteria, and craving 
scores during nondeprivation and deprivation conditions. Con-
sistent with previous research (Hatsukami et al., 1987; Hughes 
& Hatsukami, 1986; Hughes et al., 1990; Keenan, Hatsukami, 
& Anton, 1989), it was predicted that smokeless users and cig-
arette smokers would show signifi cant increases in withdrawal 
and craving at 24-hr and 48-hr deprivation compared to a 0-hr 
(prequit) baseline. Furthermore, it was expected that smokeless 
users and cigarette smokers would endorse substantially higher 
withdrawal and craving symptoms during the deprivation condi-
tion compared to the nondeprivation condition. Potential differ-
ences in withdrawal severity between smokeless users and ciga-
rette smokers will also be examined. 
Method
Participants 
Nineteen male (10 smokeless, 9 smokers) undergraduate stu-
dents participated in the study. The participants’ ages ranged 
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from 18 to 21 years. Thirteen participants were recruited from in-
troductory psychology courses at Oklahoma State University and 
were given extra credit in their psychology classes as compensa-
tion for their participation. Six participants were volunteers from 
the campus population. 
Participants included in the study were at least 18 years old, 
reported at least 1 year of continuous and daily nicotine use, 
were not currently attempting to stop or cut down on smoking or 
smokeless use, and did not report a history of multiple forms of 
nicotine use (e.g., smokes and uses smokeless tobacco). Smoking 
participants used an average of 13.9 (SD = 6.8) cigarettes per day, 
consumed 4.8 (SD = 2.4) packs per week, and averaged 5.2 (SD 
= 2.9) years of continuous use. Smokeless tobacco users on aver-
age reported using moist snuff products continuously for 4.0 (SD 
= 1.7) years, took 4.7 (SD = 1.2) dips per day, and consumed 2.9 
(SD = 1.0) tins per week. 
Materials 
The Withdrawal Symptom Checklist (WSC) is a 12-item 
checklist structured in a Likert-scale format (0 = not present; 1 
= mild; 2 = moderate; 3 = severe). This checklist was developed 
and standardized by Hughes and Hatsukami (1986) to assess nic-
otine withdrawal. Several symptoms detail a range of nicotine 
withdrawal criteria in the DSM-IV. Extracted DSM-IV criteria al-
low for the comparison between total nicotine withdrawal and 
DSM-IV nicotine withdrawal severity. The instrument has been 
shown to be valid and reliable (Hughes & Hatsukami, 1986). 
Procedure 
Informed consent was obtained from all participants. Cigarette 
smokers (CIG) and smokeless tobacco (SMT) participants were 
assigned to deprivation conditions and nondeprivation condi-
tions. Both conditions were counterbalanced. Five of the 10 SMT 
participants and 4 of the 9 CIG participants were assigned to the 
deprivation condition fi rst and the nondeprivation condition sec-
ond. During the deprivation condition, CIG and SMT participants 
were instructed to abstain from smoking or smokeless tobacco 
use for 48 hr, respectively. During the nondeprivation condition, 
CIG participants were instructed to maintain their smoking be-
havior for 48 hr, and SMT participants were instructed to main-
tain their smokeless tobacco use without increasing or decreasing 
the amount of consumption for 48 hr. 
Data was collected at 0 hr (prequit), 24 hr, and 48 hr during 
each condition. All participants used their preferred nicotine 
product for 10 min before the administration of the WSC at 0 hr. 
Subsequent WSC assessments were taken 24 hr and 48 hr after 
the 0-hr assessment period. 
A carbon monoxide (COa) level was also taken during 0-hr, 
24-hr, and 48-hr deprivation and nondeprivation assessment pe-
riods. Although COa levels do not detect smokeless tobacco use, 
CIG and SMT participants were told that COa levels would iden-
tify nicotine in the system. COa levels represented a bogus pipe-
line for the SMT users and provided a measure of smoking behav-
ior for CIG participants. CIG participants were required to score 
above 8 ppm during the nondeprivation condition and below 4 
ppm during the deprivation condition. COa assessments were im-
plemented to increase compliance rates for all participants. Par-
ticipants were debriefed following the last assessment period. 
Results
Total withdrawal symptoms on 12 specifi c withdrawal symp-
toms were computed for each participant during all 3  deprivation 
and nondeprivation days. Craving scores and six DSM-IV with-
drawal criteria items (i.e., irritability, anxiety, diffi culty concen-
trating, restlessness, hunger, and insomnia) were extracted from 
the participants’ reported total withdrawal symptoms. Mixed de-
sign analyses of variance (ANOVAs) comparing repeated mea-
sures of time (0 hr, 24 hr, 48 hr) and condition (deprivation vs. 
nondeprivation) with group (CIG vs. SMT) were conducted on 
DSM-IV criteria withdrawal scores, total withdrawal scores, and 
craving scores. 
Total withdrawal, DSM-IV withdrawal, and craving did not 
produce signifi cant fi ndings for the Group × Condition × Time, 
Group × Condition, Group × Time, or Group comparisons. Sig-
nifi cant differences for the Condition × Time interaction were 
found for total withdrawal, F(2, 34) = 8.13, p < .001, DSM-IV 
withdrawal, F(2, 34) = 11.29, p < .0001, and craving, F(2, 34) = 
12.41, p < .0001 (see Figure 1). 
Tukey comparisons demonstrated signifi cant total with-
drawal differences between 48-hr deprivation and 48-hr non-
deprivation for all three measures. DSM-IV and craving scores 
showed similar differences comparing deprivation and nondepri-
vation days at 24 hr. All signifi cant differences were found at the 
p < .05 alpha level. 
Figure 1. Mean withdrawal differences between deprivation and symp-
toms were computed for each participant during all 3 nondeprivation 
conditions for smokers and smokeless users. 
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Mean deprivation and nondeprivation COa levels were cal-
culated for both CIG and SMT participants. CIG participants’ 
COa nondeprivation levels were 11.7 ppm (SD = 5.3) at baseline, 
14.4 ppm (SD = 7.4) at 24 hr, and 12.8 ppm (SD = 5.4) at 48 hr. 
CIG participants’ COa deprivation levels were 13.0 ppm (SD = 
6.7) at baseline, 2.9 ppm (SD = 0.9) at 24 hr, and 2.4 ppm (SD = 
1.0) at 48 hr. SMT participants’ COa nondeprivation levels were 
0.2 ppm (SD = 0.4) at baseline, 0.3 ppm (SD = 0.7) at 24 hr, and 
0.2 ppm (SD = 0.4) at 48 hr. SMT participants’ deprivation COa 
levels were 0.2 ppm (SD = 0.4) at baseline, 0.1 ppm (SD = 0.3) at 
24 hr, and 0.3 ppm (SD = 0.5) at 48 hr. 
Discussion
The results of this study partially supported the overall hy-
potheses. Nicotine users, regardless of nicotine type, showed sig-
nifi cant increases in their withdrawal and craving symptoms as a 
function of 48-hr deprivation compared to 48-hr nondeprivation. 
Unexpectedly, smokeless users and cigarette smokers did not re-
port substantial increases in withdrawal when compared to a 0-hr 
prequit day. Consistent with previous research (Hatsukami et al., 
1987), however, there were no signifi cant group differences be-
tween smokeless users’ and cigarette smokers’ withdrawal. Fur-
thermore, the reported quantitative differences in withdrawal of 
cigarette smokers compared to smokeless users, which was doc-
umented by Hatsukami et al. from observed differences in signif-
icant alpha levels (smokers, p < .01; smokeless users, p < .05), 
was not demonstrated in this study. 
This study attempted to provide an alternative method of 
measuring withdrawal symptoms and severity. Similar to the Hat-
sukami et al. (1987) study comparing smokers’ and smokeless us-
ers’ withdrawal, our study attempted to extend this research by 
replicating the comparison of 0-hr, 24-hr, and 48-hr deprivation 
days. It is still unclear in other withdrawal research, however, 
whether the typical 2 or 3 ad lib using days adequately stabilizes 
the response pattern of repeated measures before deprivation. 
Unlike Hatsukami et al. and other studies, our study attempted to 
provide a control for deprivation effects by creating the ad lib us-
ing days into a distinct 0-hr, 24-hr, and 48-hr nondeprivation con-
dition that mimics the deprivation methodology and by counter-
balancing this condition with the standard deprivation condition. 
The results demonstrated that one baseline measure (0-hr prequit) 
compared to deprivation effects does not accurately refl ect with-
drawal responsivity. As seen in Figure 1, a nonsignifi cant down-
ward trend during nondeprivation days supported the idea of sta-
bilizing response patterns before deprivation. This trend suggests 
that other effects may contaminate deprivation effects without an 
adequate control. 
Although other studies have used nondeprivation days to sta-
bilize response patterns (Hatsukami et al., 1987; Hughes & Hat-
sukami, 1986; Hughes et al., 1990), this study is the fi rst to ex-
amine the importance of stabilization. The most robust fi ndings 
occurred when we compared 48-hr nondeprivation to 48-hr de-
privation effects. These fi ndings suggest that several baseline 
measures are important for stabilizing response patterns before 
deprivation. Establishing 3 or more days of ad lib use, similar to 
Hatsukami et al., or using our methodology appears to elicit ex-
pected results. Our methodology, however, examines both nonde-
privation and deprivation effects in a more controlled fashion. 
Our results also extended nicotine-withdrawal research by 
comparing DSM-IV, craving, and total withdrawal severity. Pre-
vious studies have typically compared total withdrawal sever-
ity and craving (Hatsukami et al., 1987; Hughes & Hatsukami, 
1986; Hughes et al., 1990). The examination of DSM-IV symp-
toms compared to total withdrawal and craving adds support to 
differential response patterns that contribute to our understand-
ing of diagnosable nicotine withdrawal from general withdrawal. 
For example, DSM-IV withdrawal criteria demonstrated a quanti-
tatively shorter latency in severe withdrawal responses compared 
to total withdrawal. This effect was evinced by the signifi cant 
DSM-IV differences in 24-hr deprivation compared to 24-hr non-
deprivation comparisons. Total withdrawal comparisons lacked 
this effect. 
There are two possible limitations to this study. First, docu-
mented withdrawal in smokers and smokeless users was minimal 
compared to other studies. However, these minimal fi ndings may 
be a function of controlled novelty or anticipatory effects pro-
vided by the study’s methodology. Second, comparisons across 
products are diffi cult to interpret because differences in the ex-
tent of nicotine exposure may infl uence withdrawal. This limita-
tion is indicative of the importance in examining smokeless to-
bacco withdrawal. Previous research (Hatsukami et al., 1987) and 
this study have also provided evidence that this initial compari-
son is an important endeavor toward understanding smokeless to-
bacco withdrawal, Future research should refi ne the investigation 
of smokeless tobacco withdrawal by possibly examining poten-
tial adjuncts specifi c to smokeless tobacco use and exposure that 
may infl uence withdrawal. 
These results emphasize two important considerations with 
the study of nicotine withdrawal. First, smokeless tobacco users 
do not appear to experience less intense withdrawal patterns. It 
has been speculated that smokeless users were a less dependent 
population partially as a result of fewer withdrawal symptoms 
(Hatsukami et al., 1987). Our fi ndings, however, indicate the 
importance of future research with this population. Second, re-
peated measures may bias deprivation effects by using only base-
line comparisons. Although previous research utilized 3 nonde-
privation days before deprivation (Hatsukami et al., 1987), our 
study is the fi rst to systematically examine the importance of 
stabilization. 
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